Navigation Links
MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
Date:10/16/2007

WELLESLEY HILLS, Mass., Oct. 16 /PRNewswire-FirstCall/ -- MacroChem (OTC Bulletin Board: MACM) will participate in the PIPEs Conference 2007 to be held at the Hilton New York on October 18 and 19. The company will have an exhibit table, located outside the Sutton Room, throughout each day of the conference. MacroChem's President and Chief Executive Officer, Robert J. DeLuccia, will provide a company overview, including discussion about MacroChem's lead product, EcoNail(R), which is currently in a fully enrolled Phase 2 clinical trial. DeLuccia will also discuss MacroChem's newly acquired rights to pexiganan, a novel, topical anti-infective drug for treatment of diabetic foot infection (DFI), and its recent preferred stock conversion and private placement.

The PIPEs Conference will be a mix of education and networking with active investors in the small cap equity market. Two full days of programming will provide insight on industry developments from experts in the field, as well as networking opportunities with institutional investors, investment bankers, corporate attorneys, company executives, financial analysts, and media representatives from around the globe.

About MacroChem

MacroChem Corporation is a specialty pharmaceutical company that develops and seeks to commercialize pharmaceutical products. Our lead product candidate is EcoNail, a topically applied SEPA-based econazole lacquer for the treatment of onychomycosis, a condition commonly known as nail fungus. We recently acquired exclusive worldwide license rights to pexiganan, a novel topical anti-infective for the treatment of diabetic foot infection, which has already completed two Phase 3 trials. Our other clinical stage product candidate, Opterone(R), is a topically applied SEPA-based testosterone cream designed to treat male hypogonadism. Our pipeline of clinical-stage and early-stage product candidates is based on our SEPA(R), MacroDerm(TM) and DermaPass(TM) drug delivery technologies. For more information visit our website, http://www.macrochem.com.

Forward-Looking Statements

With the exception of historical information contained in this press release, the matters described herein are forward-looking statements that involve risks and uncertainties. MacroChem's actual results may differ significantly from the results discussed in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed or referred to in the section entitled "Risk Factors" in MacroChem's Annual Report on Form 10-K, as well as those discussed elsewhere therein, and include, without limitation, risks regarding product development, the timing and results of clinical trials, the regulatory approval process, capital requirements, financial condition, patent protection and dependence on third parties for development and licensing arrangements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. MacroChem undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. For more information visit our website, http://www.macrochem.com.

Contact:

MacroChem: Bernard Patriacca -- VP/CFO

bpatriacca@macrochem.com, (781) 489-7310

Investor Relations: The Investor Relations Group, Inc.

Christine Berni / Joseph Triunfo, (212) 825-3210

cberni@investorrelationsgroup.com, jtriunfo@investorrelationsgroup.com

Media:

Bill Douglass / Michaela Heller, (212) 825-3210

bdouglass@investorrelationsgroup.com

mheller@investorrelationsgroup.com


'/>"/>
SOURCE MacroChem Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruker Participates in Dutch Funded Super Microscope Project
2. Digital Healthcare Conference 2007: Mounting obstacles for health IT
3. Biomedical engineering conference invites manufacturers
4. Conference to address small town development
5. Wisconsin to host SBIR Conference
6. Gaming conference explores interactive media in learning
7. Digital Healthcare Conference starts on a realistic note
8. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
9. Third coast of biotechnology makes strong showing at VC conference
10. Why companies dont get invited to the DEMO conference
11. Giuliani will keynote RedPrairie Corporations user conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... genomics analysis platform specifically designed for life science researchers to analyze and ... researcher Rosalind Franklin, who made a major contribution to the discovery of ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/23/2017)... -- The report "Gesture Recognition and Touchless Sensing Market by Technology ... Forecast to 2022", published by MarketsandMarkets, the market is expected to be worth ... and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):